Xvivo Perfusion AB (publ) XVIPF Stock
Xvivo Perfusion AB (publ) Price Chart
Xvivo Perfusion AB (publ) XVIPF Financial and Trading Overview
Xvivo Perfusion AB (publ) stock price | 25.81 USD |
Previous Close | 25.35 USD |
Open | 25.35 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 25.35 - 25.35 USD |
52 Week Range | 11.15 - 29.13 USD |
Volume | 243 USD |
Avg. Volume | 11 USD |
Market Cap | 811.17M USD |
Beta (5Y Monthly) | 2.017241 |
PE Ratio (TTM) | 281.66666 |
EPS (TTM) | 0.55 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
XVIPF Valuation Measures
Enterprise Value | 756.24M USD |
Trailing P/E | 281.66666 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Xvivo Perfusion AB (publ) Stock Price History
Beta (5Y Monthly) | 2.017241 |
52-Week Change | 3.34% |
S&P500 52-Week Change | 20.43% |
52 Week High | 29.13 USD |
52 Week Low | 11.15 USD |
50-Day Moving Average | 24.95 USD |
200-Day Moving Average | 20.94 USD |
XVIPF Share Statistics
Avg. Volume (3 month) | 11 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 29.9M |
Float | 23.61M |
Short Ratio | N/A |
% Held by Insiders | 12.25% |
% Held by Institutions | 55.79% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 6.00% |
Operating Margin (ttm) | 0% |
Gross Margin | 72.65% |
EBITDA Margin | 6.48% |
Management Effectiveness
Return on Assets (ttm) | 0.74% |
Return on Equity (ttm) | 2.02% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | 51.80% |
Gross Profit (ttm) | 296.96M USD |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | 0.09 |
Quarterly Earnings Growth (yoy) | 197.50% |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | 1.29 USD |
Current Ratio (mrq) | 3.307 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Xvivo Perfusion AB (publ)
Country | United States |
State | N/A |
City | Gothenburg |
Address | MAessans gata 10 |
ZIP | 412 51 |
Phone | 46 3 17 88 21 50 |
Website | https://www.xvivoperfusion.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 137 |
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.
Q&A For Xvivo Perfusion AB (publ) Stock
What is a current XVIPF stock price?
Xvivo Perfusion AB (publ) XVIPF stock price today per share is 25.81 USD.
How to purchase Xvivo Perfusion AB (publ) stock?
You can buy XVIPF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Xvivo Perfusion AB (publ)?
The stock symbol or ticker of Xvivo Perfusion AB (publ) is XVIPF.
Which industry does the Xvivo Perfusion AB (publ) company belong to?
The Xvivo Perfusion AB (publ) industry is Medical Devices.
How many shares does Xvivo Perfusion AB (publ) have in circulation?
The max supply of Xvivo Perfusion AB (publ) shares is 31.66M.
What is Xvivo Perfusion AB (publ) Price to Earnings Ratio (PE Ratio)?
Xvivo Perfusion AB (publ) PE Ratio is 46.92727000 now.
What was Xvivo Perfusion AB (publ) earnings per share over the trailing 12 months (TTM)?
Xvivo Perfusion AB (publ) EPS is 0.55 USD over the trailing 12 months.
Which sector does the Xvivo Perfusion AB (publ) company belong to?
The Xvivo Perfusion AB (publ) sector is Healthcare.